New Results

Intranasal administration of SARS-CoV-2 neutralizing human antibody prevents infection in mice

Hongbing Zhang, Zhiyuan Yang, Jingyi Xiang, Ziyou Cui, Jianying Liu, Cheng Liu
doi: https://doi.org/10.1101/2020.12.08.416677

Article Information

doi 
https://doi.org/10.1101/2020.12.08.416677
History 
  • December 9, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Hongbing Zhang1,
  2. Zhiyuan Yang1,
  3. Jingyi Xiang1,
  4. Ziyou Cui1,
  5. Jianying Liu1 and
  6. Cheng Liu*
  1. 1Eureka Therapeutics, Inc., Emeryville, CA, USA
  1. ↵*Contact details: 5858 Horton Street, Suite 170, Emeryville CA 94608, Corresponding author. Email address: cheng.liu{at}eurekainc.com
Back to top
Posted December 09, 2020.
Download PDF
Email
Intranasal administration of SARS-CoV-2 neutralizing human antibody prevents infection in mice
Hongbing Zhang, Zhiyuan Yang, Jingyi Xiang, Ziyou Cui, Jianying Liu, Cheng Liu
bioRxiv 2020.12.08.416677; doi: https://doi.org/10.1101/2020.12.08.416677
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area